ERBB2 and breast carcinoma: In total, this suggests that the hyperglycemic effect on HER2+ breast cancer cells will lead to the loss of normal mammary cell like shape and polarity, and begin the formation of more mesenchymal-like morphologies that are indicative of invasive cancer [108].